Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France.

Date publication

mai 2016

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Dr RIOS Maria

Tous les auteurs :
Penel N, Coindre JM, Bonvalot S, Italiano A, Neuville A, Le Cesne A, Terrier P, Ray-Coquard I, Ranchere-Vince D, Robin YM, Isambert N, Ferron G, Duffaud F, Bertucci F, Rios M, Stoeckle E, Le Pechoux C, Guillemet C, Courreges JB, Blay JY

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/26974708

Résumé

The optimal management of rare tumours (i.e. from accurate diagnosis to management in reference centres) is a public health challenge. In 2009, the French National Cancer Institute (INCa) identified and financially supported the two expert networks for pathological and clinical diagnosis and management of soft tissue tumours.

Mots clés

Adolescent, Adult, Aged, Aged, 80 and over, Biomarkers, Tumor, genetics, Biopsy, Large-Core Needle, Child, Cooperative Behavior, DNA Mutational Analysis, Databases, Factual, Delivery of Health Care, Integrated, organization & administration, Early Detection of Cancer, Female, Fibromatosis, Aggressive, genetics, France, epidemiology, Genetic Predisposition to Disease, Health Care Surveys, Humans, Incidence, Male, Middle Aged, Mutation, Patient Care Team, Phenotype, Predictive Value of Tests, Program Evaluation, Quality Improvement, Quality Indicators, Health Care, Referral and Consultation, Time Factors, Time-to-Treatment, Treatment Outcome, Young Adult, beta Catenin, genetics

Référence

Eur. J. Cancer. 2016 May;58:90-6